Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil versus nitroglycerin for deliberate hypotensive anesthesia during tympanoplasty
PACTR201712002826324Completed
- Sponsor
- nagat S. Elshmaa
- Start
- Apr 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial in ear disorders comparing Nitroglycerin group with Remifentanil group (2 arms). Primary endpoints: Maintenance of mean arterial pressure and Operative site visibility. Started Apr 2016; status: completed.
02
Drugs
remifentanilnitroglycerin
03
Conditions
ear disorders
Beyond the preview
Go deeper on PACTR201712002826324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201712002826324.